Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MERS, Sars, china coronavirus, coronavirus, coronavirus China, wuhan coronaviurs

The Wuhan coronavirus continues to dominate the news, with China admitting its handling of the crisis had shortcomings while Gilead …
News
shutterstock_349943306

85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds

February 7, 2020 Medical Communications, Research and Development clinical trials, pharma

Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …
News
abbvie_0

AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3

February 6, 2020 Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis

AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …
News

How AI is making clinical trials more accurate and affordable

February 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …
Feature

NICE plans to use broader range of data in guidance

February 5, 2020 Research and Development NHS, NHS NICE, NICE

The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …
News

Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study

February 5, 2020 Research and Development Bayer, Eylea, pharma

Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …
News
white-passenger-plane-on-airport-during-daytime

Final UK flight from Wuhan to bring home Britons from coronavirus epicenter

February 5, 2020 Research and Development Wuhan Coronavirus, Wuhan Virus, china coronavirus, coronavirus

The last flight from Wuhan will arrive back in the UK on Sunday, bringing back British nationals fleeing from the …
News
holly_springs_9frontflags

Seqirus’ Audenz becomes first FDA-approved cell-based adjuvant influenza A vaccine

February 5, 2020 Research and Development, Sales and Marketing FDA, influenza, pharma, seqirus

The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …
News
assorted-condoms

Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds

February 5, 2020 Research and Development AIDS, HIV, STDs, STIs, UK, sexual health

The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …
News

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …
Feature
david_hallett

AI firm Exscientia appoints COO and Head of Drug Discovery

January 31, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exscientia, appointment

AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …
Appointment
shutterstock_159488225

Bayer and Orion’s Nubeqa shows off strong overall survival benefit in castration-resistant prostate cancer

January 31, 2020 Medical Communications, Research and Development Bayer, orion, pharma

Bayer and Finnish pharma firm Orion Corporation have announced positive new Phase 3 data for their jointly developed oral androgen …
News
pharmafocus_janfeb_2020_cover

Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
News
shutterstock_36423250

Spring Bank Pharma shuts down HBV drug development following patient death

January 30, 2020 Research and Development Spring Bank, patient death, pharma

Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …
News

Johnson & Johnson working on coronavirus vaccine

January 30, 2020 Business Services, Research and Development Chinese Coronavirus, Wuhan Coronavirus, Wuhan epidemic, coronavirus

Johnson & Johnson has become the latest pharmaceutical company to begin work on a vaccine for the Chinese coronavirus. They …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026